# Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients

> **NCT05108012** · PHASE1 · UNKNOWN · sponsor: **Royan Institute** · enrollment: 5 (estimated)

## Conditions studied

- Glioblastoma Multiform
- Recurrent Glioblastoma

## Interventions

- **BIOLOGICAL:** NK cell therapy

## Key facts

- **NCT ID:** NCT05108012
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-01
- **Primary completion:** 2021-11
- **Final completion:** 2022-04
- **Target enrollment:** 5 (ESTIMATED)
- **Last updated:** 2021-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05108012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05108012, "Nk Cell Therapy for Recurrent Glioblastoma Multiform Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05108012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*